**Core Concept**
The question is testing the understanding of the extrapyramidal side effects (EPS) associated with chronic use of antipsychotic medications. **Dopamine blockade** in the nigrostriatal pathway is a key mechanism underlying EPS. This concept is crucial in pharmacology and neurology.

**Why the Correct Answer is Right**
The correct answer is related to the concept of **Tardive Dyskinesia (TD)**. TD is a type of movement disorder characterized by repetitive, involuntary, purposeless movements. It is a well-known side effect of chronic antipsychotic use, particularly with first-generation (typical) antipsychotics. The pathophysiology of TD involves long-term blockade of dopamine D2 receptors in the striatum, leading to abnormal movement patterns. The exact mechanism is not fully understood, but it is thought to involve changes in the expression of genes related to dopamine receptors and signaling pathways.

**Why Each Wrong Option is Incorrect**
**Option A:** Akathisia is a type of EPS characterized by subjective feelings of restlessness and an urge to move. It is often seen with acute antipsychotic use, not chronic use.
**Option B:** Parkinsonism is a type of EPS that mimics Parkinson's disease, with symptoms such as tremors, rigidity, and bradykinesia. It is also more commonly seen with acute antipsychotic use.
**Option C:** Dysphonia (voice changes) is not typically associated with EPS. It can be a side effect of various medications, but it is not a characteristic symptom of antipsychotic-induced EPS.

**Clinical Pearl / High-Yield Fact**
To remember the difference between TD and other EPS, recall that TD is often associated with long-term antipsychotic use and involves abnormal, involuntary movements. Akathisia and parkinsonism, on the other hand, are more commonly seen with acute antipsychotic use and involve restlessness and movement difficulties, respectively.

**Correct Answer:** C. Tardive Dyskinesia.